Rare diseases
Investigational molecules
Locations
750 Lexington Avenue, 10022-1200, United States
Clinical research in ER-positive, HER2-negative breast cancer spans advanced and metastatic disease, with attention to endocrine-resistant disease and ESR1-mutated tumours.
Research also includes treatment settings after prior CDK4/6 inhibitor exposure and disease that has progressed despite hormonal therapy.
Stemline Therapeutics Inc. runs clinical trials in conditions such as Breast cancer metastatic, Hormone receptor positive HER2 negative breast cancer, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Belgium
AustriaAustria
BulgariaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
